Progress Software [PRGS]
As of 2026-07-30 · spot $40.01 · The memo issues no position verdict; the book decides.
Equity is the default under the brief and needs no argument. No LEAP or multi-leg structure is proposed, and the reason is stated rather than omitted:
| Spot | $40.01 |
| 12-month target (15.85x EV/EBIT, 10.1st pctile) | $44.43 (+11.0%) |
| Flip point of the valuation test (13.4x) | ~$32 |
| Window-B EV/EBIT low, 13.3x | $31.23 |
| ROIC-warranted 7.2x | $4.36 |
Invalidation, named and measurable — any one of: 1. ARR growth turns negative. Reported every quarter in the 10-Q ("Our ARR was $X and $Y"). ARR is the organic signal; revenue is not. 2. The disclosed net-retention band falls below 99%. It has already moved 100–102% → 99–100%. 3. Revolver drawn above ~$1.15bn of the $1.5bn facility, or a disclosed covenant amendment. The thesis requires that the acquisition machine keeps running; the facility is how it runs. 4. Price through $31 — that is simultaneously the valuation flip point and the regime low.
+11% to the base target against a downside that, at the ROIC-warranted multiple, is −89%. The distribution is not attractive on its face. What makes the name arguable at all is that no software business trades at its ROIC-warranted multiple, and PRGS's 15.85x is already the 10th percentile of its own post-2024 range. What makes it fragile is 42% gearing on top of that.